Non-Surgical Knee Treatments: Long-Term Solutions for Joint Pain
Surgery treats structure. Our protocols treat biology. That's why 89% of patients who were told surgery was their only option — recovered without it.
Surgery vs. OPTM Non-Surgical Protocol
Conventional Surgery
OPTM Non-Surgical Protocol
How the OPTM Protocol Works
Every non-surgical treatment follows the same three-stage sequence: find the biological root cause, correct it at the cellular level, then rebuild the biomechanics that broke down. This is why results are long-term rather than temporary.
Assess — Map the Root Cause
A 60+ biomarker blood panel analyses inflammation load, muscle age, metabolic markers, and joint-health signals before any treatment is prescribed. Your plan is built on data, not guesswork.
Treat — Correct the Biology
Phyto-molecular compounds, condition-specific nutrition, and fibrosis-management protocols reduce inflammatory cytokines and support tissue repair — without steroids, injections, or scalpels.
Restore — Rebuild and Prevent
Movement RX reconditions the muscles and biomechanics that caused your joint to fail, so the improvement is permanent. Most patients feel measurable relief within 2–3 weeks.
Our Treatment Portfolio
AI Biomarker Diagnostics
60+ blood biomarkers — including muscle age, inflammatory cytokines, and metabolic markers — guide every treatment decision. No guessing.
Phyto-Molecular Therapy
Concentrated plant compounds targeting inflammation, cartilage repair, muscle regeneration, and pain reduction at a cellular level.
Bio-Musculo Index (BMI) Optimisation
Your biological muscle age vs. your chronological age. We reverse the gap using personalised nutritional and movement protocols.
Movement RX
Evidence-based progressive exercise programmes building joint stability, restoring biomechanics, and preventing recurrence.
Nutritional Therapy
Condition-specific nutrition protocols that change the inflammatory environment — the foundation all other treatments build on.
Advanced Fibrosis Management
Targeted manual and therapeutic techniques to break down scar tissue and restore tissue mobility in post-injury or post-surgical cases.
Conditions We Treat Without Surgery
Scientific Evidence Base
The biomarkers measured in OPTM's diagnostic panel are grounded in peer-reviewed medical literature.
About the Bio-Musculo Index Methodology
The Bio-Musculo Index (BMI) is a proprietary multi-biomarker diagnostic panel developed by Dr. Apurba Ganguly (PhD Biochemistry, DSc, Post-Doctorate Fellow) over 35+ years of clinical research. It aggregates individually validated blood biomarkers — including inflammatory cytokines, oxidative stress markers, cartilage degradation indicators, and metabolic parameters — into a composite AI-assisted index. Dr. Ganguly's own peer-reviewed publications (indexed on NIH/PubMed, ResearchGate, IABCR, and Longdom Publishing) form the primary evidence base for this protocol.
All citations below are authored or co-authored by Dr. Apurba Ganguly — Founder & Chief Research Officer, OPTM Healthcare. View full publication list at ResearchGate or SciProfiles.
Molecular signatures of varicosity: Diagnostic insights from ten biomarker panels
Ganguly A, Ganguly Anondeep. (2025). Molecular signatures of varicosity: Diagnostic insights from ten biomarker panels. PubMed Central (NIH). PMC12694810.
View Publication →Relevance: Dr. Ganguly's 2025 NIH-indexed research on multi-biomarker diagnostic panels — the methodology used in OPTM's Bio-Musculo Index
Pain diagnostic protocol and topical phytotherapeutic treatment for osteoarthritic disorders and prevention
Ganguly A. Pain diagnostic protocol and topical phytotherapeutic treatment for osteoarthritic disorders and prevention. International Online Medical Council (IOMC) Proceedings.
View Publication →Relevance: Dr. Ganguly's clinical research on OPTM's pain diagnostic and phytotherapeutic treatment protocol for osteoarthritis
Efficacy of Phytotherapeutic Protocol for the Risk Factor Reduction in Musculoskeletal Degeneration: A Systematic Meta-Analysis
Ganguly A. (2024). Efficacy of Phytotherapeutic Protocol for the Risk Factor Reduction in Musculoskeletal Degeneration: A Systematic Meta-Analysis. International Archives of BioMedical and Clinical Research (IABCR), Vol. 10, Issue 1, Mar 2024.
View Publication →Relevance: Dr. Ganguly's peer-reviewed meta-analysis validating OPTM's phytotherapy protocol for musculoskeletal risk factor reduction
Find Out if You Can Avoid Surgery
Assessment includes 60+ biomarker tests, expert consultation, and a personalised non-surgical plan.